Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus

NCT00195468 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure
Graft vs Host Disease

Interventions

DRUG: CYCLOSPORINE

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer